Working with a team of more than 100 UCSF specialists, Tippi MacKenzie, MD, and Elliott Vichinsky, MD, are leading work to bring cutting edge therapies to patients with genetic blood disorders.
For Dr. Vichinsky, this work began more than 30 years ago, when most patients with these disorders died in infancy. Today, thanks to cutting edge research and revolutions in patient care, patients are living much longer, higher quality lives.
This work took a major leap forward in the fall of 2017, when his colleague Dr. MacKenzie launched the world’s first clinical trial of an in-utero stem cell transplant therapy. Her first patient, baby Elianna, was born just four months later.
Now 18 months old, she is being treated by Dr. Vichinsky. Elianna's birth came after a second-trimester diagnosis of a normally fatal blood disorder, Alpha Thalassemia Major. Her story hints at the lifesaving possibilities of fetal therapy for families who face similarly devastating diagnoses.
Dr. Tippi MacKenzie, a pediatric surgeon at UCSF Benioff Children's Hospital and its Fetal Treatment Center, has special interests in fetal surgery, advanced laparoscopy, and endocrine and biliary surgery. She is a member of the Biomedical ...
This Video Content is available for informational and educational purposes only. UCSF does not make any representation or warranties with respect to the accuracy, applicability, fitness, or completeness of the Video Content. The Regents of the University of California and its officers, agents or employees (UCSF) will not be liable for any damages of any kind arising from any use of the Video Content, which is provided as is, and without warranties. The Video Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read or seen on the Site.